Automated Modelling of Cortical Bone from Clinical CT by Pearson, Rose Alicia
AUTOMATED MODELLING OF CORTICAL BONE FROM CLINICAL CT
ROSE ALICIA PEARSON
SUMMARY OF THESIS
Osteoporosis is an age-related skeletal disease characterised by an increased incidence of
fragility fractures. In this thesis I develop a new technique capable of measuring the thickness
of the previously unmeasured endocortical region, and providing an improved measure of the cor-
tical bone mineral density (cBMD) from in-vivo clinical CT scans. These features are of interest
as both have been linked to fracture risk.
The new technique is developed within the cortical bone mapping (CBM) framework so that it
provides localised architectural measurements over a bone’s surface. Its performance is assessed
using simulated QCT data from three simulated phantoms with differing bone architecture, and
two paired datasets of ex-vivo QCT and HR-pQCT scans across the proximal femur and the lum-
bar spine. The simulated data allows for inaccuracies in CBM measurements caused by beam
hardening effects to be considered for the first time: I show that beam hardening leads to an
underestimation in cortical thickness and an overestimation in trabecular BMD and that these in-
accuracies can be reduced through adjustments to the CBM optimisation process.
A new technique of analysing HR-pQCT scans is also developed, for the validation of the new
CBM method. It was used in place of other established HR-pQCT techniques for its ability to
provide localised measurements of the endocortical region. A comparison with the well known
full-width half-maximum (FWHM) method shows that it is less susceptible to errors caused by
beam hardening. It also measures the mean cBMD, which has a greater clinical relevance than the
peak cBMD measured by the FWHM method as it includes the impact of porosity. I demonstrate
that the endocortical thickness can be measured to an accuracy of −0.15 ± 0.71mm, and that
local cBMD measurements are possible down to 300mg/cm3 from QCT scans over the proximal
femur. I also validate CBM methods over the vertebrae for the first time and demonstrate that the
cortical thickness and endocortical thickness can be measured with accuracies of 0.10± 0.30mm
and −0.20± 0.53mm.
Two clinical trials involving Teriparatide are used to demonstrate that the new CBM method
is able to detect significant regional changes in the dense cortical and endocortical bone over the
proximal femur and lumbar spine, which can be attributed to changes in intracortical remodelling
and endosteal apposition. The analysis of a cross-sectional fracture discrimination trial shows that
fracture incidence is associated with significant decreases in endocortical thickness over specific
regions.
